homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
Last edited:
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis
- Thread starter Imogene
- Start date